v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue ($ from related party for the three months ended xxx, respectively) $ 1,499 $ 2,667 $ 3,896 $ 5,020
Operating expenses:        
Research and development 18,942 27,692 39,553 63,223
General and administrative 7,896 10,403 15,962 20,138
Asset, Impairment Loss 0 12,150 0 12,150
Total operating expenses 26,838 50,245 55,515 95,511
Loss from operations (25,339) (47,578) (51,619) (90,491)
Other income (expense)        
Impairment Of Equity Method Investment 0 (9,158) 0 (9,158)
Other income, net 1,057 2,638 2,252 5,560
Total other income (expense) 1,057 (6,520) 2,252 (3,598)
Net loss (24,282) (54,098) (49,367) (94,089)
Other comprehensive loss        
Net unrealized loss on available-for-sale marketable securities, net of tax (48) (127) (174) (215)
Net comprehensive loss $ (24,330) $ (54,225) $ (49,541) $ (94,304)
Net loss per share, basic (in dollars per share) $ (0.24) $ (0.58) $ (0.50) $ (1.01)
Net loss per share, diluted (in dollars per share) $ (0.24) $ (0.58) $ (0.50) $ (1.01)
Weighted-average common shares outstanding, basic (in shares) 100,985,698 93,028,698 98,437,862 92,855,060
Weighted-average common shares outstanding, diluted (in shares) 100,985,698 93,028,698 98,437,862 92,855,060